Blog

NASH: IHC Digital Assays for Immune Cell Quantification

Research into developing effective treatments for non-alcoholic steatohepatitis (NASH) is becoming more important as the incidence of NASH increases in the general population. Mouse and rat models are used in the development of NASH therapeutics to help investigators better understand the pathophysiological mechanisms of the disease. Treatment strategies for NASH that target and modulate the …

NASH: IHC Digital Assays for Immune Cell Quantification Read More »

Deep Learning-Based Assessment and Sophisticated Quantification for Wound Healing and Skin Metrics

The staggering cost of healthcare in America continues to rise, especially for wound healing. In 2014, wound-related healthcare expenses for Medicare beneficiaries were conservatively estimated at $28.1 billion, with over 8 million patients reporting at least one type of wound or infection.1 Improved methods that analyze the complex stages of wound healing have potential to …

Deep Learning-Based Assessment and Sophisticated Quantification for Wound Healing and Skin Metrics Read More »

AI: Advancing Patient Access and Outcomes

Biocom’s 4th Annual Big Data Summit, held October 29, 2019 in La Jolla, CA, brought together thought leaders in artificial intelligence (AI), computational drug discovery, and blockchain technology. Throughout the day a recurring theme emerged: machine learning improves the affordability, speed, quality and utility of complex applications. Technology advancements over the last 5 years have …

AI: Advancing Patient Access and Outcomes Read More »

AACR Highlights: Focus on AI

The 110th Annual Meeting of the American Association for Cancer Research launched on March 30th, 2019 in Atlanta, GA. Over 22,000 delegates attended including scientists, clinicians, and patient advocates from around the globe. A team from Reveal Biosciences was present to highlight our recent advances in the application of artificial intelligence (AI) in pathology for …

AACR Highlights: Focus on AI Read More »

Inside the Slide: Episode 1

We are proud to present the premier episode of our “Inside the Slide” video series. In this first episode, we examine a whole slide image of a prostate tissue sample stained with hemotoxylin and eosin (H&E). In the coming months, we will explore more whole slide images of different tissue types and staining techniques we …

Inside the Slide: Episode 1 Read More »

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice

Reveal Biosciences attended Biocom’s recent CRO seminar on Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice. Pharmatest Services and Taconic Biosciences hosted this informative seminar where they presented on humanized immune system models for immunotherapies and on humanized mouse models of bone metastasis. Paul Volden, Associate Director of External Collaboration and Innovation at Taconic …

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice Read More »

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston

Reveal Biosciences Founder and CEO, Dr. Claire Weston, was recently featured in the Tech Spotlight interview series. This interview covered topics such as the inception of Reveal Biosciences, the future impact of AI on pathology, and more. You can read the full interview on the Managed Solution website by clicking here. Here’s Claire’s response to …

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston Read More »

Reveal Biosciences Webinar Recap: Revolutionize Pathology Using Artificial Intelligence

Casey Laris, CTO of Reveal Biosciences, lead a webinar entitled “Revolutionize Pathology using Artificial Intelligence” as part of the Science Exchange Webinar Series. Highlights from this webinar include: Reveal Biosciences specializes in data powered pathology. The company offers a range of histopathology, immunohistochemistry (IHC), in situ hybridization (ISH), whole slide imaging and advanced image analysis …

Reveal Biosciences Webinar Recap: Revolutionize Pathology Using Artificial Intelligence Read More »

Precision Histology: Artificial Intelligence as a Tool for Pathologists

The hematoxylin and eosin (H&E) stain has long been an essential tool in the pathologist’s arsenal. Positively-charged hematoxylin and negatively-charged eosin bind to different substances within a tissue sample. This allows pathologists to clearly view different structures within that sample in various shades of blue, violet, and red. Once stained, the tissue sample can be …

Precision Histology: Artificial Intelligence as a Tool for Pathologists Read More »